GLP1R response to GLP-1 weight-loss medicines
GLP1R response to GLP-1 weight-loss medicines is a genetic trait Biome reports in its medication response panel: In one large study, each T copy was linked to about 1.7 pounds more weight loss and more nausea or vomiting on semaglutide or tirzepatide. The weight result repeated in another study; the side-effect result has not.
- Category
- Medication response
- Markers
- GLP1R rs10305420
- Strength of evidence
- Research-grade — no prescribing guideline
- DNA-test coverage
- If covered
Genes
Markers (rsIDs)
How Biome reads this
Biome's whole-genome test reads this from one saliva sample, alongside all 3.2 billion letters of your DNA.
Biome DNA test →This page is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Genetic results describe tendencies and predispositions, not diagnoses. Always consult a licensed clinician before making decisions about your health, medications, or supplements.